Cargando…

Pharmacokinetics, safety and tolerability of human recombinant alkaline phosphatase in healthy volunteers

Detalles Bibliográficos
Autores principales:	Peters, E, Arend, J, Tiessen, R, Van Elsas, A, Masereeuw, R, Pickkers, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471820/ http://dx.doi.org/10.1186/cc14206

Ejemplares similares

Pharmacokinetic Modeling and Dose Selection in a Randomized, Double-Blind, Placebo-Controlled Trial of a Human Recombinant Alkaline Phosphatase in Healthy Volunteers
por: Peters, Esther, et al.
Publicado: (2016)

Alkaline phosphatase treatment improves renal function in patients with severe sepsis or septic shock
por: Heemskerk, S, et al.
Publicado: (2007)

Human rhinovirus infection induces local and systemic immunological tolerance in healthy volunteers
por: Koch, RM, et al.
Publicado: (2015)

Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI)
por: Peters, Esther, et al.
Publicado: (2016)

New markers of inflammation-induced renal injury subside when endotoxin tolerance develops in humans as measured by urine proteomics
por: Heemskerk, S, et al.
Publicado: (2010)

Inflammation-induced renal injury subsides when endotoxin tolerance develops in humans as measured by urine proteomics
por: Draisma, A, et al.
Publicado: (2009)

Interplay between the innate immune response and heart rate variability in healthy human volunteers
por: Kox, M, et al.
Publicado: (2011)

Phase I single and multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of BMS-927711 in healthy subjects
por: Tong, G, et al.
Publicado: (2013)

Safety, tolerability and pharmacokinetics of subcutaneous and intravenous anifrolumab in healthy volunteers
por: Tummala, Raj, et al.
Publicado: (2018)

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral Venglustat in Healthy Volunteers
por: Peterschmitt, M. Judith, et al.
Publicado: (2020)

Upregulation of renal inducible NO synthase and proximal tubule damage during human endotoxemia
por: Heemskerk, S, et al.
Publicado: (2004)

The pharmacokinetic and safety profile of raltegravir and ribavirin, when dosed separately and together, in healthy volunteers
por: Ashby, J, et al.
Publicado: (2010)

Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of Vixotrigine in Healthy Volunteers
por: Naik, Himanshu, et al.
Publicado: (2020)

Evaluation of the safety, tolerability, and pharmacokinetics of RO7049389 in healthy Chinese volunteers
por: Wu, Xiaojie, et al.
Publicado: (2021)

The Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GSK1322322 in Healthy Volunteers
por: Naderer, Odin, et al.
Publicado: (2015)

Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers
por: Al‐Karagholi, Mohammad Al‐Mahdi, et al.
Publicado: (2021)

Pharmacokinetics, Safety, and Tolerability of Single-Dose Orally Administered Venglustat in Healthy Chinese Volunteers
por: Li, Yingxin, et al.
Publicado: (2023)

Phase I studies of the safety, tolerability, pharmacokinetics, and pharmacodynamics of DS‐1211, a tissue‐nonspecific alkaline phosphatase inhibitor
por: Maruyama, Sonomi, et al.
Publicado: (2022)

Effect of eight days bed rest on the incretin effect in healthy volunteers
por: Nielsen, ST, et al.
Publicado: (2015)

A Randomized Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Recombinant Erwinia Asparaginase (JZP‐458) in Healthy Adult Volunteers
por: Lin, Tong, et al.
Publicado: (2021)

Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers
por: Orrell, Catherine, et al.
Publicado: (2008)

Effect of Probenecid on Pharmacokinetics and Tolerability of Olmesartan in Healthy Chinese Volunteers()
por: Li, Kun-Yan, et al.
Publicado: (2014)

Effects of enalaprilat sodium on plasma NTproANP and NTproBNP levels in healthy volunteers
por: Heringlake, M, et al.
Publicado: (2006)

Innovative Drugs to Target Renal Inflammation in Sepsis: Alkaline Phosphatase
por: Hümmeke-Oppers, Femke, et al.
Publicado: (2019)

Safety, tolerability, and pharmacokinetics of AL-335 in healthy volunteers and hepatitis C virus-infected subjects
por: McClure, Matthew W., et al.
Publicado: (2018)

A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers
por: Johansson, Susanne, et al.
Publicado: (2016)

Effectiveness and safety of recombinant activated factor
por: Echarri González, G, et al.
Publicado: (2006)

Assessment of the interstitial volume in healthy volunteers. An equilibrium contrast CMR study
por: Sado, Daniel, et al.
Publicado: (2012)

Noninvasive alveolar recruitment maneuver induces cytokine release in healthy volunteers
por: Malbouisson, L, et al.
Publicado: (2007)

Reproducibility and variability of left ventricular 4D flow in healthy volunteers
por: Stoll, Victoria, et al.
Publicado: (2015)

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Hyaluronidase PH20 Administered Intravenously in Healthy Volunteers
por: Printz, Marie A., et al.
Publicado: (2020)

Safety, pharmacokinetics, and pharmacodynamics of 4-hour intravenous infusion of eritoran tetrasodium in healthy Japanese and Caucasian males
por: Okubo, Y, et al.
Publicado: (2011)

Pharmacokinetics, pharmacodynamics, safety and tolerability of cilofexor, a novel nonsteroidal Farnesoid X receptor agonist, in healthy volunteers
por: Younis, Islam R., et al.
Publicado: (2023)

Respiratory variability of aortic blood velocity: predictor of preload responsiveness in healthy spontaneously breathing volunteers
por: Skulec, R, et al.
Publicado: (2005)

Safety, Tolerability, and Pharmacokinetics of Recombinant Human Neuregulin-1 in Healthy Chinese Subjects
por: Xu, Junyu, et al.
Publicado: (2023)

CMR derived MAPSE and TAPSE Measurements in hypertrophic cardiomyopathy: comparison to healthy volunteers
por: Abdel-Aty, Hassan, et al.
Publicado: (2012)

The effect of sumatriptan on cephalic arteries - 3T MR-angiography study in healthy volunteers
por: Amin, FM, et al.
Publicado: (2013)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers
por: Monteith, David, et al.
Publicado: (2017)

Phase 1 Dose‐Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Tofacitinib in Japanese Healthy Volunteers
por: Miyoshi, So, et al.
Publicado: (2019)

Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers
por: Family, Neiloufar, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d8mtvji8g0rl6mcqammibo4e4d